GlobalData on MSN
Dexcom gives sneak preview of CGM technologies’ long-term health benefits for diabetics
Dexcom will present the full data from several studies at the Advanced Technologies and Treatments for Diabetes conference, ...
Dexcom will stop producing G6 CGM sensors July 1, 2026, urging patients to switch to the smaller, more accurate G7 model.
DexCom, Inc. (NASDAQ:DXCM) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February 13, William Plovanic from Canaccord Genuity reduced the price target on DexCom ...
PCMag Australia on MSN
I Tracked My Blood Sugar With a Dexcom Stelo for a Month. Here's What I Learned
The Stelo is available to anyone who wants to monitor their blood glucose, no prescription needed. But as an active adult ...
DexCom, Inc. , the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for people with all types of diabetes and share more ...
New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.
One underappreciated reason why I feel DXCM could potentially gain more favorable interest is because its long-suffering ...
DexCom, Inc. (DXCM) 47th Annual Raymond James Institutional Investor Conference March 2, 2026 1:05 PM ESTCompany ParticipantsJereme Sylvain - Executive ...
Abbott recalled certain sensors used in its FreeStyle Libre 3 and FreeStyle Libre 3 Plus systems, warning they could produce ...
Senseonics' Eversense 365 drives 72% Q4 growth as company reclaims U.S. commercialization and targets 65-76% revenue increase in 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results